4D Molecular Therapeutics (FDMT) Receivables - Net (2019 - 2021)
4D Molecular Therapeutics (FDMT) reported Receivables - Net of $47000.0 for Q4 2021, down 96.84% year-over-year from $1.5 million in Q4 2020, and down 94.06% quarter-over-quarter from $791000.0 in Q3 2021.
4D Molecular Therapeutics (FDMT) Receivables - Net (2019 - 2021) Analysis & Trends
4D Molecular Therapeutics (FDMT) has 3 years of Receivables - Net data on file, last reported at $47000.0 in Q4 2021.
- Receivables - Net for Q4 2021 came in at $47000.0, down 96.84% year-over-year; the trailing twelve-month figure through Dec 2021 was $47000.0 (down 96.84% YoY), and the FY2021 annual result was $47000.0, down 96.84% from the prior year.
- Receivables - Net declined to $47000.0 in Q4 2021 per FDMT's latest filing, from $791000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $1.5 million in Q4 2020 and troughed at $47000.0 in Q4 2021.
- A 3-year average of $825500.0 and a median of $884500.0 in 2019 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2020 and 2021: Receivables - Net soared 51.94% in 2020, then tumbled 96.84% in 2021.
- A 3-year view of Receivables - Net shows it stood at $978000.0 in 2019, then soared by 51.94% to $1.5 million in 2020, then plunged by 96.84% to $47000.0 in 2021.
- Business Quant data shows FDMT's Receivables - Net at $47000.0 in Q4 2021, $791000.0 in Q3 2021, and $1.5 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 47,000.00 |
| Dec 31, 2021 | 47,000.00 |
| Sep 30, 2021 | 791,000.00 |
| Sep 30, 2021 | 791,000.00 |
| Dec 31, 2020 | 1.49 Mn |
| Dec 31, 2020 | 1.49 Mn |
| Dec 31, 2019 | 978,000.00 |
| Dec 31, 2019 | 978,000.00 |